Fresh Tracks Therapeutics, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 1 | $1.58 | $1.58 | $1.58 |
| Q2 2024 | 1 | $1.34 | $1.34 | $1.34 |
| Q3 2024 | 1 | $1.54 | $1.54 | $1.54 |
Fresh Tracks Therapeutics, Inc. Earnings Date And Information
Fresh Tracks Therapeutics, Inc. last posted its earnings results on Tuesday, March 21st, 2023. The company reported $-2.7 earnings per share for the quarter, missing analysts' consensus estimates of $-1.43 by $1.27. The company had revenue of 0 for the quarter and had revenue of 8.01 M for the year. Fresh Tracks Therapeutics, Inc. has generated $-1 earnings per share over the last year ($-0.96 diluted earnings per share) and currently has a price-to-earnings ratio of -3.04. Fresh Tracks Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 5th, 2024 based on prior year's report dates.
Fresh Tracks Therapeutics, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 12/30/2023 | Q4 2023 | -$0.21 | $6.00 M | $0 | ||
| 11/13/2023 | Q3 2023 | $0.32 | $7.94 M | |||
| 08/11/2023 | Q2 2023 | -$0.39 | $53,000 | |||
| 05/10/2023 | Q1 2023 | -$1.12 | $9,000 | |||
| 05/01/2023 | Q4 2022 | -$1.38 | $2.50 M | $2.05 M | ||
| 11/10/2022 | Q3 2022 | -$2.05 | $486,000 | |||
| 08/11/2022 | Q2 2022 | -$0.31 | $4.32 M | |||
| 05/12/2022 | Q1 2022 | -$2.59 | -$3.55 | -0.96 | $92,000 | |
| 03/15/2022 | Q4 2021 | -$3.82 | -$2.53 | 1.29 | $104,000 | |
| 11/09/2021 | Q3 2021 | -$5.62 | -$7.15 | -1.53 | $132,000 | |
| 08/12/2021 | Q2 2021 | -$5.62 | -$7.29 | -1.67 | $151,000 | |
| 05/13/2021 | Q1 2021 | -$5.17 | -$6.63 | -1.46 | $17,000 | |
| 03/09/2021 | Q4 2020 | -$4.05 | -$6.84 | -2.79 | $27,000 | |
| 11/12/2020 | Q3 2020 | -$8.32 | -$6.93 | 1.39 | $142,000 | |
| 08/12/2020 | Q2 2020 | -$19.49 | $607,000 | |||
| 05/13/2020 | Q1 2020 | -$20.28 | $1.05 M | |||
| 03/18/2020 | Q4 2019 | -$61.94 | $669,000 | |||
| 11/13/2019 | Q3 2019 | -$73.08 | $1.18 M | |||
| 07/12/2019 | Q2 2019 | -$34.65 | -$33.54 | 1.11 | $2.57 M | |
| 05/02/2019 | Q1 2019 | -$56.70 | -$349.79 | -293.09 | $3.49 M |
Fresh Tracks Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Fresh Tracks Therapeutics, Inc.'s earnings date?
Fresh Tracks Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 5th, 2024 based off last year's report dates.
-
How can I listen to Fresh Tracks Therapeutics, Inc.'s earnings conference call?
The conference call for Fresh Tracks Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Fresh Tracks Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Fresh Tracks Therapeutics, Inc.'s latest earnings report can be read online.
-
How much revenue does Fresh Tracks Therapeutics, Inc. generate each year?
Fresh Tracks Therapeutics, Inc. (:FRTX) has a recorded annual revenue of $8.01 M.
-
How much profit does Fresh Tracks Therapeutics, Inc. generate each year?
Fresh Tracks Therapeutics, Inc. (:FRTX) has a recorded net income of $8.01 M. Fresh Tracks Therapeutics, Inc. has generated $-0.96 earnings per share over the last four quarters.
-
What is Fresh Tracks Therapeutics, Inc.'s price-to-earnings ratio?
Fresh Tracks Therapeutics, Inc. (:FRTX) has a price-to-earnings ratio of -3.04 and price/earnings-to-growth ratio is -0.07.
